Physician profile
Tyson J Thorpe
NPI 1699170688
$2,525.48
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.44 · 2022: $2,292 · 2023: $161 · 2024: $33.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181 · Education: $13.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.79 |
| Education | $13.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,239.53 | 2022-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $74.44 | 2022-2024 | |
| Sk Life Science, INC. | $34.76 | 2022-2023 | |
| Alkermes, INC. | $24.52 | 2021 | |
| Inspire Medical Systems, INC. | $24.30 | 2023 | Inspire |
| Sunovion Pharmaceuticals INC. | $23.08 | 2022 | |
| Sumitomo Pharma America, INC. | $22.22 | 2023 | Aptiom |
| Amneal Pharmaceuticals LLC | $20.91 | 2023 | Rytary |
| Jazz Pharmaceuticals INC. | $20.36 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.92 | 2021 | |
| Neurelis, INC. | $13.40 | 2024 | Valtoco |
| Boston Scientific Corporation | $13.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyson Thorpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.